IRON
NASDAQ
$74.38
Disc Medicine Inc (IRON)
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $101.55 (+36.53%)
Market Cap
$2.90B
FCF 5Y CAGR
+105.14%
Free Cash Flow Yield
-6.93%
Beta (5Y)
1.15
Price Chart
Valuation
Market Cap$2.90B
P/B4.17
Profitability
EBITDA-$265M
EPS-$6.63
Financial Health
Debt-to-Equity4.3%
Free Cash Flow Yield-6.93%
Growth & Risk
FCF 5Y CAGR+105.14%
Beta (5Y)1.15
Sharpe Ratio0.67